2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)

被引：0
|
作者：
S Yokota
T Imagawa
T Miyamae
K Kasai
M Mori
N Nishimoto
T Kishimoto
机构：
[1] Yokohama City University,
[2] Osaka University,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Corticosteroid; Respiratory Tract Infection; Juvenile Idiopathic Arthritis; Gastroenteritis; Tocilizumab;
D O I：
10.1186/1546-0096-6-S1-S1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The Long-Term Outcome of Juvenile Idiopathic Arthritis
    Ravelli, Angelo
    Martini, Alberto
    CURRENT RHEUMATOLOGY REVIEWS, 2005, 1 (02) : 151 - 155
  • [22] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Takako Miyamae
    Tomoyuki Imagawa
    Shigeki Katakura
    Rumiko Kurosawa
    Masaaki Mori
    Clinical Reviews in Allergy & Immunology, 2005, 28 : 231 - 237
  • [23] Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis
    Inaba, Yutaka
    Ozawa, Remi
    Aoki, Chie
    Imagawa, Tomoyuki
    Mori, Masaaki
    Hara, Ryoki
    Miyamae, Takako
    Saito, Tomoyuki
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2013, 23 (04) : 667 - 673
  • [24] PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
    S Yokota
    T Nozawa
    T Kanetaka
    K Yamazaki
    T Sato
    N Sakurai
    M Kikuchi
    Pediatric Rheumatology, 11 (Suppl 2)
  • [25] Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis
    Kotaniemi, Kaisu
    Saila, Hanna
    Kautiainen, Hannu
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 1425 - 1429
  • [26] Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy
    Nozawa, Tomo
    Nishimura, Kenichi
    Ohara, Asami
    Hara, Ryoki
    Ito, Shuichi
    MODERN RHEUMATOLOGY, 2019, 29 (03) : 558 - 562
  • [27] Efficacy and safety of tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis
    Gronlund, Minna-Maija
    Remes-Pakarinen, Terhi
    Kroger, Liisa
    Markula-Patjas, Kati
    Backstrom, Maria
    Putto-Laurila, Anne
    Aalto, Kristiina
    Vahasalo, Paula
    RHEUMATOLOGY, 2020, 59 (04) : 732 - 741
  • [28] Long-term efficacy and safety of adalimumab in 4-12 year old patients with juvenile idiopathic arthritis
    N Ruperto
    DJ Lovell
    A Reiff
    M Gamir
    G Higgins
    I Koné-Paut
    OY Jones
    E Chalom
    N Ilowite
    C Wouters
    MJ McIlraith
    S Liu
    H Kupper
    EH Giannini
    A Martini
    Pediatric Rheumatology, 9 (Suppl 1)
  • [29] Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Zhang, Xiaoping
    Morcos, Peter N.
    Saito, Tomohisa
    Terao, Kimio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02) : 123 - 137
  • [30] The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab
    Sagawa, Akira
    MODERN RHEUMATOLOGY, 2011, 21 (04) : 352 - 358
12345